Pesquisar
IQVIA Holdings Inc
IQVAdicionar à lista de desejos
185.620USD
0.0000.00%
Fechamento 06/24, 16:00（ET）Cotações atrasadas em 15 min
30.98BValor de mercado
22.86P/L TTM
Mais detalhes de IQVIA Holdings Inc Empresa
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Informações de IQVIA Holdings Inc
Código da empresaIQV
Nome da EmpresaIQVIA Holdings Inc
Data de listagemMay 09, 2013
CEOBousbib (Ari)
Número de funcionários88000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 09
Endereço2400 Ellis Road
CidadeDURHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal27703
Telefone19199982000
Sitehttps://ir.iqvia.com/
Código da empresaIQV
Data de listagemMay 09, 2013
CEOBousbib (Ari)
Executivos da empresa IQVIA Holdings Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.41M
+2.04%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
65.53K
+14.55%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
30.89K
+15.83%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.32K
+5.25%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
16.95K
+9.27%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
14.45K
+10.87%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
5.96K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
3.03K
+71.48%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
1.06K
--
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.41M
+2.04%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
65.53K
+14.55%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
30.89K
+15.83%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.32K
+5.25%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
16.95K
+9.27%
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
14.45K
+10.87%
Perguntas frequentes
Quem são os cinco principais acionistas de IQVIA Holdings Inc?
Os cinco principais acionistas de IQVIA Holdings Inc são: Mr. Ari Bousbib
Quantas instituições possuem ações da IQVIA Holdings Inc (IQV)?
Em 2026Q1, 2209 instituições possuíam ações da IQVIA Holdings Inc, com valor de mercado aproximado de 173.06M, representando 103.69% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -9598327.00.
